Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialMagdy Selim, Heena Olalde, Lydia D. Foster et al.|The Lancet Neurology|2019Cited by 249
Predicting symptomatic intracranial haemorrhage after mechanical thrombectomy: the TAG scoreMayra Montalvo, Shadi Yaghi, Katarina Dakay et al.|Journal of Neurology Neurosurgery & Psychiatry|2019Cited by 72